Pain severity contributes to worse outcomes in opioid use disorder recovery than pain status
- PMID: 39817932
- DOI: 10.1016/j.drugalcdep.2024.112530
Pain severity contributes to worse outcomes in opioid use disorder recovery than pain status
Abstract
Background: Opioid use disorder (OUD) continues to pose a significant challenge to public health in the United States. Chronic pain and OUD are highly comorbid conditions, yet few studies have examined the relative associations of pain status and severity toward multidimensional OUD recovery outcomes (e.g., psychopathology and withdrawal).
Methods: Participants (N = 214) were from the RECOVER-LT study, conducted 4.2-years after completion of a clinical trial program assessing extended-release buprenorphine. Group differences by pain status (i.e., chronic, acute, or no pain) were evaluated in this cross-sectional data set using analysis of variance and Fisher's exact test. Linear regression was utilized to understand the associations between average pain severity and recovery outcomes. Model selection was performed to examine the relative importance of pain status and average pain severity to recovery outcomes.
Results: A majority of the sample endorsed chronic pain (73.8 %). The multivariate regression analysis with model selection found that higher average pain severity (p < .001), but not pain status, was significantly associated with the multidimensional recovery outcomes greater total number of DSM-5 OUD symptoms, higher opioid withdrawal score, reduced physical quality of life, higher depressive symptoms, negative affect, and greater psychological distress. Pain status and average pain severity were not associated with past 7- or 30-day opioid use (p > 0.001).
Conclusions: These findings highlight pain severity, but not pain status, as a key dimension of OUD recovery. This suggests a need for integration of OUD treatment and pain management, particularly for individuals experiencing elevated pain severity regardless of pain status.
Keywords: Chronic pain; Opioid use disorder; Pain severity; Pain status; Recovery.
Copyright © 2024. Published by Elsevier B.V.
Conflict of interest statement
Declaration of Competing Interest Although the following activities/relationships do not create a conflict of interest pertaining to this manuscript, in the interest of full disclosure, Drs. Bickel and Tegge would like to report the following: W. K. Bickel is a principal of HealthSim, LLC; BEAM Diagnostics, Inc.; and Red 5 Group, LLC. In addition, he serves on the scientific advisory board for Ria Health; and serves as a consultant for Lumanity. A. N. Tegge works on a project supported by Indivior. W. H. Craft, C. L. Dwyer, L. N. Athamneh, and D. R. Keith have no conflicts of interest to disclose. J. S. Stein has received subcontract funding through an NIH grant awarded to BEAM Diagnostics, Inc. Lastly, A. Le Moigne, A. M. DeVeaugh-Geiss, H. D. Chilcoat are employees of Indivior
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
